Filing Flows › Pulse Biosciences (PLSE) › Q3 2026 › vs Q2 2026
Pulse Biosciences (PLSE) Q3 2026 vs Q2 2026 (quarter over quarter)
Pulse Biosciences's revenue fell $39K (-9%) from $434K in Q2 2026 to $395K in Q3 2026.
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $395K | $434K | −$39K | -9% |
| Other income, net | $1.2M | $615K | $626K | +102% |
| Net loss | $23.1M | $24.7M | −$1.6M | -7% |
| Costs & expenses | $24.7M | $25.7M | −$1.0M | -4% |
| Operating costs | $24.7M | $25.7M | −$1.0M | -4% |
| Cost of revenue | $191K | $273K | −$82K | -30% |
| Research & development | $16.8M | $17.0M | −$128K | -0.8% |
| SG&A | $7.6M | $8.5M | −$809K | -10% |
| Operating cash sources | $23.1M | $24.7M | −$1.6M | -7% |
| Depreciation & amortization | $261K | $254K | $7K | +3% |
| Share-based compensation | $5.3M | $5.0M | $339K | +7% |
| Working capital & other | $2.2M | $721K | $1.5M | +206% |
| Cash used in operations | $15.3M | $18.7M | −$3.4M | -18% |
| Net loss absorbed | $23.1M | $24.7M | −$1.6M | -7% |
Questions
How much did Pulse Biosciences's revenue grow quarter over quarter in Q3 2026?
Pulse Biosciences's revenue fell $39K (-9%) from $434K in Q2 2026 to $395K in Q3 2026.